Showing 1 - 2 of 2
Persistent link: https://www.econbiz.de/10002951029
Research concerning the pharmaceutical industry rate of return has concentrated on two policy issues: (1) possible resource misallocation and (2) the drug innovation environment. Accounting returns are suspect for policy purposes, requiring attention to the role of, and impact on, expectations...
Persistent link: https://www.econbiz.de/10008839126